284620 — Kainos Medicine Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- KR₩36bn
- KR₩37bn
- KR₩590m
Annual balance sheet for Kainos Medicine, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 29,812 | 34,231 | 29,952 | 16,337 | 3,834 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 82.9 | 300 | 329 | 207 | 542 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 31,987 | 36,873 | 31,236 | 17,117 | 4,604 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,851 | 3,334 | 5,437 | 875 | 603 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 34,779 | 41,957 | 38,982 | 20,985 | 10,742 |
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,167 | 25,655 | 8,678 | 5,129 | 4,698 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 22,426 | 29,853 | 12,873 | 9,234 | 8,954 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 12,353 | 12,104 | 26,109 | 11,751 | 1,788 |
| Total Liabilities & Shareholders' Equity | 34,779 | 41,957 | 38,982 | 20,985 | 10,742 |
| Total Common Shares Outstanding |